Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06425029 · ClinicalTrials.gov registry record · NA
Self-administered ONe-of-a Kind Approach to Epilepsy Therapy Through a Web-based Music Application
A NA study of Epilepsy and Refractory Epilepsy, sponsored by Dartmouth-Hitchcock Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 2
- Study locations
NCT06425029: Recruiting NA study of Epilepsy and Refractory Epilepsy, sponsored by Dartmouth-Hitchcock Medical Center.
NCT06425029 is a NA study of Epilepsy and Refractory Epilepsy that is actively recruiting participants, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 24 participants, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06425029, a NA study of Epilepsy and Refractory Epilepsy, is actively recruiting participants, sponsored by Dartmouth-Hitchcock Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a prospective, placebo-controlled, double-blinded randomized study of self-administered auditory intervention in a naturalistic home environment.
Primary Outcome
This measure aims to determine if specific music intervention has positive effect on epileptic activity in participants with responsive neurostimulation device (RNS) implanted for drug-resistant epilepsy (DRE). The effect will be measured as a change in the number of "long episodes" or epileptic activity in a participants' brain as detected and recorded by the RNS device before and after study music interventions.
Conditions Studied
Interventions
- OTHER Experimental Intervention (Music A)
- OTHER Active Comparator Intervention (Music B)
- OTHER Active Comparator Intervention (Music C)
Study Locations (2)
Massachusetts
- University of Massachusetts Chan Medical School - Worcester
New Hampshire
- Dartmouth-Hitchcock Medical Center - Lebanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2025-07-22 |
| Est. Completion | 2026-12-01 |
| Phase | NA |
What NCT06425029 shows while recruiting
NCT06425029 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (97% lower).
The record links to 3 conditions, with Epilepsy appearing as the primary indexed condition, and to 3 interventions - of which Experimental Intervention (Music A) is the first listed.
NCT06425029 reports a single indexed study location in Massachusetts, New Hampshire.
Frequently Asked Questions
What is clinical trial NCT06425029 about?
NCT06425029 is a clinical study titled "Self-administered ONe-of-a Kind Approach to Epilepsy Therapy Through a Web-based Music Application". This is a prospective, placebo-controlled, double-blinded randomized study of self-administered auditory intervention in a naturalistic home environment.
What is the current status of trial NCT06425029?
This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2025-07-22. Estimated completion is 2026-12-01.
What conditions does trial NCT06425029 study?
This clinical trial studies the following conditions: Epilepsy, Refractory Epilepsy, Music.
What interventions are being tested in trial NCT06425029?
The interventions under investigation include: Experimental Intervention (Music A) (OTHER), Active Comparator Intervention (Music B) (OTHER), Active Comparator Intervention (Music C) (OTHER).
Who is sponsoring clinical trial NCT06425029?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06425029 being conducted?
This trial has 2 study locations across Massachusetts, New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06425029's enrollment target sits among peer trials
24 123rd of 160 higher than 32 of 160 other Epilepsy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Epilepsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SeizEAR Safety Study
RECRUITING · NA
-
Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients
RECRUITING · NA
-
Subcortical Arousal in Perceptual Awareness
RECRUITING · NA
-
Prediction of Anxiety and Memory State
RECRUITING · NA
-
Implementation and Cost Evaluation of Project UPLIFT
RECRUITING · NA
-
Amygdala Memory Enhancement
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI